Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (5) , 1029-1036
- https://doi.org/10.1111/j.1538-7836.2006.01882.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materialsBlood Coagulation & Fibrinolysis, 2005
- Genetic and Environmental Determinants of Fibrin Structure and FunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Update on Statins: 2003Circulation, 2004
- New nonlipid effects of statins and their clinical relevance in cardiovascular diseaseThrombosis and Haemostasis, 2004
- Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?Current Opinion in Lipidology, 2003
- Dynamic Changes of Fibrin Architecture during Fibrin Formation and Intrinsic Fibrinolysis of Fibrin-rich ClotsJournal of Biological Chemistry, 2003
- Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis ProcessesDrugs, 2003
- Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery DiseaseCirculation, 2002
- Statins and Blockers of the Renin-Angiotensin SystemHypertension, 1999
- The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activatorBlood Coagulation & Fibrinolysis, 1995